- South Korea
- /
- Semiconductors
- /
- KOSDAQ:A089030
3 KRX Insider Picks With Earnings Growth Up To 99%
Reviewed by Simply Wall St
The South Korean market has experienced a modest uptick, rising 1.1% over the last week and 4.9% over the past year, with earnings projected to grow by 30% annually. In this favorable environment, companies with high insider ownership and strong earnings growth potential are particularly appealing as they often indicate confidence from those closest to the business in its future prospects.
Top 10 Growth Companies With High Insider Ownership In South Korea
Name | Insider Ownership | Earnings Growth |
People & Technology (KOSDAQ:A137400) | 16.4% | 35.6% |
Seojin SystemLtd (KOSDAQ:A178320) | 30.8% | 49.1% |
Bioneer (KOSDAQ:A064550) | 15.8% | 97.6% |
Oscotec (KOSDAQ:A039200) | 26.1% | 122% |
ALTEOGEN (KOSDAQ:A196170) | 26.6% | 99.5% |
HANA Micron (KOSDAQ:A067310) | 18.3% | 105.8% |
Vuno (KOSDAQ:A338220) | 19.4% | 110.9% |
UTI (KOSDAQ:A179900) | 33.1% | 134.6% |
Techwing (KOSDAQ:A089030) | 18.7% | 83.6% |
INTEKPLUS (KOSDAQ:A064290) | 16.3% | 96.7% |
Let's dive into some prime choices out of the screener.
Techwing (KOSDAQ:A089030)
Simply Wall St Growth Rating: ★★★★★★
Overview: Techwing, Inc. develops, manufactures, sells, and services semiconductor inspection equipment in South Korea and internationally with a market cap of ₩1.34 trillion.
Operations: Techwing's revenue is primarily derived from its semiconductor inspection equipment business, which operates both domestically in South Korea and internationally.
Insider Ownership: 18.7%
Earnings Growth Forecast: 83.6% p.a.
Techwing is experiencing significant revenue growth, with a forecasted annual increase of 62.5%, outpacing the South Korean market's average. Despite recent net losses, analysts expect profitability within three years, driven by an anticipated 83.65% annual earnings growth and a projected high return on equity of 50%. However, financial stability remains a concern as interest payments are not well covered by earnings and share price volatility persists without substantial insider trading activity recently.
- Get an in-depth perspective on Techwing's performance by reading our analyst estimates report here.
- Insights from our recent valuation report point to the potential overvaluation of Techwing shares in the market.
ALTEOGEN (KOSDAQ:A196170)
Simply Wall St Growth Rating: ★★★★★★
Overview: ALTEOGEN Inc. is a biotechnology company specializing in the development of long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars, with a market cap of ₩20.53 trillion.
Operations: The company generates revenue of ₩90.79 million from its biotechnology segment.
Insider Ownership: 26.6%
Earnings Growth Forecast: 99.5% p.a.
ALTEOGEN is poised for substantial growth, with revenue expected to rise by 64.2% annually, significantly outpacing the South Korean market average. Analysts forecast profitability within three years, driven by an impressive projected earnings growth of 99.46% per year and a very high return on equity of 66.3%. Despite past shareholder dilution, the stock trades at a significant discount to its estimated fair value, offering potential upside as it transitions towards profitability.
- Click here and access our complete growth analysis report to understand the dynamics of ALTEOGEN.
- The analysis detailed in our ALTEOGEN valuation report hints at an inflated share price compared to its estimated value.
Doosan (KOSE:A000150)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Doosan Corporation operates in heavy industry, machinery manufacturing, and apartment construction across South Korea and globally, with a market cap of ₩2.93 trillion.
Operations: The company's revenue is primarily derived from Doosan Bobcat with ₩9.31 billion, followed by Doosan Energy at ₩8.25 billion, Electronic BG at ₩855.42 million, Doosan Fuel Cell at ₩279.99 million, and Digital Innovation BU contributing ₩286.29 million.
Insider Ownership: 38.9%
Earnings Growth Forecast: 65.5% p.a.
Doosan's growth prospects are tempered by a forecasted revenue increase of 3.7% annually, which lags behind the South Korean market average. However, analysts expect it to achieve profitability within three years with earnings projected to grow at 65.51% per year and a high return on equity of 20%. The stock trades significantly below its estimated fair value and was recently added to the S&P Global BMI Index, indicating potential recognition in global markets.
- Click to explore a detailed breakdown of our findings in Doosan's earnings growth report.
- Our valuation report unveils the possibility Doosan's shares may be trading at a discount.
Turning Ideas Into Actions
- Delve into our full catalog of 86 Fast Growing KRX Companies With High Insider Ownership here.
- Got skin in the game with these stocks? Elevate how you manage them by using Simply Wall St's portfolio, where intuitive tools await to help optimize your investment outcomes.
- Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.
Seeking Other Investments?
- Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
- Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
- Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Valuation is complex, but we're here to simplify it.
Discover if Techwing might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
About KOSDAQ:A089030
Techwing
Develops, manufactures, sells, and services semiconductor inspection equipment in South Korea and internationally.
Exceptional growth potential with imperfect balance sheet.